OVID THERAPEUTICS INC (OVID) — insider trading
Health Care · NASDAQ
OVID THERAPEUTICS INC (OVID) has 12 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 12 (latest 2026-07-06).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Carter Charles Ross | Officer (Chief Financial Officer) | Grant / award / vesting | 50,000 | — | $0 | Form 4 |
| 2026-06-15 | Greka Anna | Director | Grant / award / vesting (derivative) | 130,000 | — | $0 | Form 4 |
| 2026-04-07 | Fitzgerald Kevin Joseph | Director | Grant / award / vesting | 17,578 | $2.56 | $45.0K | Form 4 |
| 2026-04-07 | Friedman Bart | Director | Grant / award / vesting | 8,789 | $2.56 | $22.5K | Form 4 |
| 2026-04-07 | PAPADOPOULOS STELIOS | Director | Grant / award / vesting | 17,578 | $2.56 | $45.0K | Form 4 |
| 2026-03-23 | LEVIN JEREMY M | Director, Officer (Executive Chairman) | Option exercise / conversion (derivative) | 47,333 | — | $0 | Form 4 |
| 2026-03-23 | LEVIN JEREMY M | Director, Officer (Executive Chairman) | Option exercise / conversion | 47,333 | $1.40 | $66.3K | Form 4 |
| 2026-02-26 | LEVIN JEREMY M | Director | Grant / award / vesting (derivative) | 957,000 | — | $0 | Form 4 |
| 2026-02-26 | Fitzgerald Kevin Joseph | Director | Grant / award / vesting (derivative) | 65,000 | — | $0 | Form 4 |
| 2026-02-26 | PAPADOPOULOS STELIOS | Director | Grant / award / vesting (derivative) | 65,000 | — | $0 | Form 4 |
| 2026-02-26 | ALEXANDER MARGARET A. | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 1,435,000 | — | $0 | Form 4 |
| 2026-02-23 | ALEXANDER MARGARET A. | Director, Officer (President and CEO) | Open-market sale | 11,656 | $1.45 | $16.9K | Form 4 |
Ask the chat about OVID's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: OVID THERAPEUTICS INC (OVID).
Last updated 2026-07-06 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.